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ABSTRACT
High levels of rRNA synthesis by RNA polymerase I
are important for cell growth and proliferation.
In vitro studies have indicated that the formation
of a stable complex between the HMG box factor
[Upstream binding factor (UBF)] and SL1 at the
rRNA gene promoter is necessary to direct multiple
rounds of Pol I transcription initiation. The recruit-
ment of SL1 to the promoter occurs through protein
interactions with UBF and is regulated by phos-
phorylation of UBF. Here we show that the protein
kinase CK2 co-immunoprecipitates with the Pol I
complex and is associated with the rRNA gene
promoter. Inhibition of CK2 kinase activity reduces
Pol I transcription in cultured cells and in vitro.
Significantly, CK2 regulates the interaction between
UBF and SL1 by counteracting the inhibitory effect
of HMG boxes five and six through the phosphoryla-
tion of specific serines located at the C-terminus of
UBF. Transcription reactions with immobilized
templates indicate that phosphorylation of CK2
phosphoacceptor sites in the C-terminal domain of
UBF is important for promoting multiple rounds of
Pol I transcription. These data demonstrate that
CK2 is recruited to the rRNA gene promoter and
directly regulates Pol I transcription re-initiation by
stabilizing the association between UBF and SL1.
INTRODUCTION
RNA polymerase I (Pol I) is responsible for the synthesis of
the large ribosomal RNA (rRNA) precursor, which is then
processed into the three large ribosomal RNAs, 28S, 18S
and 5.8S in mammals (1,2). rRNA transcription is critical
for cell survival and its activity is exquisitely regulated dur-
ing cell cycle progression and cell proliferation. Transcription
of the rRNA gene is initiated by the assembly of RNA poly-
merase I and a deﬁned set of transcription factors at the rRNA
gene promoter to form the pre-initiation complex (PIC). The
nucleation of these factors at the promoter requires a complex
network of protein–protein and protein–DNA interactions.
Upstream binding factor (UBF) is an HMG box-containing
factor that binds to the rRNA gene promoter and is respons-
ible for the recruitment of the species-speciﬁc selectivity fac-
tor 1 (SL1). SL1 is a complex composed of TBP and three
TBP-associated factors (TAFs), TAFI48, TAFI63 and
TAFI110 (3–11). Studies using a cell-free system indicated
that SL1 binds directly to UBF and is brought to the promoter
by speciﬁc protein interaction between two of its subunits,
TBP and TAFI48, and UBF (12–14). The formation of the
UBF–SL1 complex at the rRNA gene promoter promotes
the recruitment of the RNA polymerase I enzyme, which
occurs via interactions between UBF and Pol I, and between
SL1 and the bridging factor Rrn3 (also termed TIF-IA) (15–
17). The assembly of the PIC and the transition from a closed
to an open complex leads to promoter clearance and trans-
cription elongation. As RNA polymerase I moves away
from the promoter, a new Pol I/Rrn3 complex would then
be recruited through interactions with the promoter-bound
UBF–SL1 complex. Based on this model, a stable UBF–
SL1 complex at the rRNA gene promoter would support
high rates of rRNA synthesis by promoting multiple rounds
of transcription initiation. Although the key role of UBF in
nucleating the PIC at the rRNA promoter has been recently
challenged (18), recent in vivo data have clearly demonstrated
that SL1 and Pol I are recruited to chromatin through protein
interactions with UBF (19,20).
The activity of UBF is regulated by posttranslational
modiﬁcations such as acetylation and phosphorylation. CBP-
dependent acetylation of UBF stimulates Pol I transcription
by counteracting the inhibitory effect of pRb (21–23) and a
recent study has shown that acetylation of UBF stimulates
its interaction with Pol I, suggesting that the acetylation status
of UBF inﬂuences the assembly of the PIC at the rRNA
promoter (24).
In addition to acetylation, the activity of UBF is regulated
by phosphorylation. Metabolic labeling studies of cultured
mammalian cells demonstrated that UBF is phosphorylated
under normal growth condition and both UBF phosphory-
lation and RNA polymerase I transcription increase upon
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function of phosphorylation in the regulation of UBF activity
has been demonstrated in several studies. SV40 large T anti-
gen, a viral oncogenic protein that promotes cell growth, sti-
mulates Pol I transcription by recruiting to the rRNA gene
promoter a cellular kinase that phosphorylates UBF (27,28).
Pol I transcriptional activity during the progression of the
cell cycle is modulated, at least in part, by phosphorylation
of UBF by cyclin-dependent kinases (CDK)–cyclin com-
plexes (29,30). Reversible UBF phosphorylation of two N-
terminal HMG boxes by ERK plays an important role in sti-
mulation of rRNA gene transcription (31,32). Collectively,
these studies provide compelling evidence for the important
role that phosphorylation of UBF plays in the regulation of
Pol I transcription. Phosphorylation of UBF has been
shown to affect its DNA binding activity (31) and its interac-
tion with other components of the transcriptional apparatus
(14–33). By employing in vitro protein–protein interaction
and DNase I footprinting assays we have shown that the
phosphorylation status of UBF plays a key role in modulating
the interaction between UBF and SL1 and in the recruitment
of SL1 to the promoter elements of the rRNA genes (14).
Moreover, mitogen-induced phosphorylation of UBF has
been shown to promote its association with TBP, one of the
SL1 subunits (34). However, the amino acid residues in
UBF whose phosphorylation is necessary for SL1 binding
and the cellular kinase responsible for their phosphorylation
remain to be identiﬁed. The C-terminal region of UBF is
particularly rich in phosphorylation sites for the protein
kinase CK2, a ubiquitous serine/threonine kinase involved
in cell growth, proliferation and survival, and kinase assays
with puriﬁed factors have shown that UBF is phosphorylated
by CK2 in vitro (25,35). CK2 is composed of two catalytic
a and/or a0 subunits, and two regulatory b subunits
(36). Genetic studies in yeast and mammalian cells have
indicated that CK2 is required for cell viability and for cell
to progress through the cell cycle. CK2 is thought to particip-
ate in a wide array of cellular processes as a growing number
of physiological targets for CK2 have been identiﬁed (36).
Notably, a number of recent studies have also shown
that CK2 directly regulates RNA polymerase II and III
transcription (37–40).
In this study we examined the role of CK2 in the
regulation of Pol I transcription. Our data indicate that CK2
is physically associated with the RNA polymerase I/Rrn3
complex and is present at the promoter region of the rRNA
genes. Studies with a CK2-speciﬁc inhibitor and reconstituted
transcription assays demonstrate that CK2 activity inﬂuences
Pol I transcription in vitro and in cultured cells. Importantly,
our results indicate that CK2-mediated phosphorylation of
UBF counteract the negative effect of HMG boxes ﬁve and
six and stabilizes the interaction of this factor with SL1,
thus promoting multiple rounds of Pol I transcription.
MATERIALS AND METHODS
Cell lines
HEK293, HEK293T and normal diploid human ﬁbroblast
were cultured in DMEM media containing 10% fetal bovine
serum in 5% CO2 at 37 C. Hela S3 suspension cells were
cultured in MEM media containing 5% newborn bovine
serum at 37 C.
Nuclear and Nucleolar fractionation
Nuclear extracts were prepared from HeLa S3 cells as
described by Zhai et al. (28). Nucleoli were prepared from
4 liters of exponentially growing HeLa S3 (3–5 · 10
5 cells/
ml) as described previously (41). Nucleolar proteins were
extracted in 2 ml of TM buffer (50 mM Tris–HCl, pH 7.9,
12.5 mM MgCl2, 1 mM EDTA, 10% glycerol, 1 mM DTT)
containing 0.1 M KCl, 0.1% Nonidet P-40 (NP-40) and pro-
tease inhibitors. Nucleolar extract was then applied to a Poros
HQ column equilibrated in TM buffer containing 0.1 M KCl
and 0.1% NP-40, washed with the same buffer, and eluted
with a 0.1–0.8 M KCl gradient in TM buffer containing
0.1% NP-40.
Protein purification
Partially puriﬁed Pol I, SL1, and UBF were prepared from
HeLa nuclear extract as previously described (41). Brieﬂy,
nuclear extracts prepared from HeLa S3 cells were applied
on a heparin–agarose column and RNA Pol I, UBF and
SL1 were eluted with a 0.1–1.0 M KCl linear gradient in
TM buffer (50 mM Tris, pH 7.9, 12.5 mM MgCl2,1m M
EDTA, 10% glycerol, 1 mM DTT, 1 mM phenylmethylsulfo-
nyl ﬂuoride). Fractions containing Pol I/Rrn3 (eluted at
 250 mM KCl) were pooled and dialyzed against TM buffer
containing 0.1 M KCl and loaded onto a Poros Q–Sepharose
column equilibrated against TM containing 0.1 M KCl. Pro-
teins were eluted with a salt gradient from 0.1 to 0.7 M KCl.
The active fractions were pooled, dialyzed to 0.125 M KCl,
aliquoted and stored at  80 C. The RNA polymerase I frac-
tion does not contain any detectable UBF or SL1, as determ-
ined by immunoblot analysis. Fractions from the heparin to
agarose column containing SL1 (eluted at  550 mM KCl)
were pooled and dialyzed against TM/0.2 M KCl. The SL1
pool was loaded on to a SP–Sepharose column (Pharmacia)
pre-equilibrated in TM/0.2 M KCl, and after extensive
washes with TM/0.2 M KCl, SL1 was eluted with TM/0.8
M KCl and dialyzed against TM/0.1 M KCl. The fractions
from the heparin to agarose column containing UBF (eluted
at  350 mM KCl) were pooled and further puriﬁed by frac-
tionation on a Q–Sepharose (Poros) column. Recombinant
UBF used in the transcription assays in-solution was puriﬁed
from baculovirus-infected cells as previously described (14).
Recombinant ﬂag-tagged UBF FL, UBF670C, UBF9A/G and
UBF9D/E, that were used in the transcription assays with
immobilized template (IT) were expressed and puriﬁed
from Sf9 insect cells infected with recombinant baculoviruses
as the following protocol: 24 h post infection, Sf9 cells were
collected, washed with PBS, and lysed in RIPA buffer. Cell
lysates were incubated with anti-ﬂag M2 agarose (Sigma)
for 1 h. Extensive washes were carried out ﬁrst with RIPA
buffer and then sequentially with TM buffer containing
0.1% NP-40 decreasing salt concentrations (0.6, 0.3 and
0.1 M NaCl). The bound proteins were then eluted by incuba-
tion with TM buffer containing 0.1% NP-40, 0.1 M NaCl and
0.3 mg/ml ﬂag peptide, and subjected to dialysis in TM buffer
containing 0.1 M NaCl and 0.1% NP-40 to remove the ﬂag
peptide. All the buffers contain a cocktail of protease
inhibitors and 1 mM DTT.
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HeLa or HEK293 cells were cross-linked by incubation with
1% formaldehyde for 10 min at room temperature. Cells were
swelled in hypotonic buffer [3 mM MgCl2, 10 mM NaCl,
10 mM Tris–HCl (pH 7.4), and 0.1% NP-40], and nuclei
were then pelleted by centrifugation. Nuclei were lysed in
nuclear lysis buffer [1% SDS, 10 mM EDTA, 50 mM Tris–
HCl (pH 8.1)]. The nuclear lysate was sonicated to generate
0.5–1 kbp chromatin fragments. After centrifugation, the
supernatant was diluted 1:5 with dilution buffer [0.01%
SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris–
HCl (pH 8.1), 167 mM NaCl], and pre-cleared with protein
A/G Sepharose mixture that was pre-blocked with BSA and
yeast tRNA. For each immunoprecipitation, the pre-cleared
lysate (equivalent to  6 · 10
6 cells) was incubated with
5 ml of the appropriate rabbit antiserum or 3 mg of antibodies
purchased from Santa Cruz, overnight at 4 C, followed by
incubation with blocked protein A/G Sepharose mixture for
1 h, or incubated with blocked anti-FLAG M2 agarose
beads for 2 h. Beads were sequentially washed in low salt
buffer (20 mM Tris–HCl at pH 8.0, 2 mM EDTA, 0.2%
SDS, 0.5% Triton X-100, 150 mM NaCl), high salt buffer
(20 mM Tris–HCl at pH 8.0, 2 mM EDTA, 0.2% SDS,
0.5% Triton X-100, 500 mM NaCl), LiCl wash buffer
(10 mM Tris–HCl at pH 8.0, 1 mM EDTA, 250 mM LiCl,
0.5% SDS, 0.5% NP-40), low salt buffer, and TE
(pH 8.0). The bound DNA was then eluted, and reverse
cross-linked. After phenol/chloroform-extraction, and
ethanol-precipitation, DNA was resuspended in 30 mlo f
water. PCR was performed in 50 ml of reaction mixture
containing 2 ml of DNA, 25 mlo f2 · SYBR Green PCR Mas-
ter Mix (Bio-Rad) and 250 nM primers. Accumulation of
ﬂuorescent product was monitored by real-time PCR using
iCycler detection system (Bio-Rad). The cycling conditions
were 95 C for 2 min, followed by 45 cycles of 95 C for
30 s, 52 C for 30 s and 72 C for 30 s. The sequences of
primers used in the PCR are as follows: rRNA promoter
region: 50-GGTATATCTTTTCGCTCCGAG-30 and 50-AGC-
GACAGGTCGCCAGAGGA-30; 18S coding region: 50-AG-
TCGGGTTGCTTGGGAATGC-30 and CCCTTACGGTAC-
TTGTTGACT-30; termination region: 50-ACCTGGCGCTA-
AACCATTCGT-30 and 50-GGACAAACCCTTGTGTCGA-
GG-30. A series of dilutions of input DNA were run alongside
the chromatin immunoprecipitation (ChIP) samples to estab-
lish the standard curve for each pair of primers. Statistical
signiﬁcance of the differences between two groups was
determined by the two-tailed Student’s t-test.
Antibodies
Rabbit antisera against UBF, TAF1110, and afﬁnity-puriﬁed
rabbit antibody against TBP were described previously (41).
Polyclonal rabbit antiserum against Pol Ib0 subunit (194 kDa)
was a gift from Dr Rothblum. Goat polyclonal antibodies
against CK2a (sc-6480 and sc-6479) and TAFII32
(sc-1248) were purchased from Santa Cruz.
TBB treatment and RNA analysis
HEK293 cells were seeded at 1.5 · 10
6 per 9.6 mm plate
1 day before treatment. The drug treatment was performed
by adding TBB (CalBiochem) to the medium at ﬁnal
concentration of 80 mM. After incubation for the indicated
time length, total cellular RNA was isolated using the Trizol
reagent. RNA was analyzed by nuclease S1 protection assay
or RT–PCR. The nuclease S1 protection assays employed a 50
end-labeled DNA oligonucleotide complementary to the
region from  20 to 40 of rRNA gene as previously described
(14). Reverse transcription (RT) was performed for 50 min at
60 C using 2 mg of RNA, 20 pmole pre-rRNA or GAPDH
reverse primer, and 15 U thermoscript reverse transcriptase
(Invitrogen) in a total volume of 20 ml of cDNA synthesis
buffer containing 5 mM DTT and 1 mM dNTP mix. One
microliter of pre-rRNA or GAPDH cDNA was ampliﬁed by
PCR with 23 or 18 cycles, respectively. Primers used were
pre-rRNA forward primer (50-CCTGCTGTTCTCTCGCGC-
GTCCGAG-30), pre-rRNA reverse primer (50-AACGCCT-
GACACGCACGGCACGGAG-30), GAPDH forward primer
(50-ACCACAGTCCATGCCATCAC-30), and GAPDH
reverse primer (50-TCCACCACCCTGTTGCTGTA-30).
In solution transcription reactions
Transcription assays were performed with partially puriﬁed
Pol I, SL1, and recombinant UBF. Transcription assays and
the analysis of in vitro-synthesized RNA by nuclease S1 pro-
tection assays were performed as previously described (41).
Immobilized DNA template assay
The IT was generated by PCR using prHu3 as the template,
and a 50-biotinylated primer (50-CGAATTCGTTTTCCGA-
GATCCCCGTGG) and 30-primer (50-CACGGTGGCCCTC-
GCCGCCTTC). The template was puriﬁed by Qiagen gel
extraction kit and then attached with the Dynal M-280 mag-
netic beads as described in the manufacturer’s instructions.
Approximately 30 ng DNA template was immobilized on
1 ml of beads (1 mg/ml). Beads attached to the DNA template
were pre-blocked with BSA at ﬁnal concentration of 5 mg/ml
for 30 min. Once prepared, the IT was immediately used for
PIC formation as described below. IT (5 ml at 1 mg/ml bead
conc.) was ﬁrst incubated with  0.1 mg of recombinant wild
type UBF or mutated UBF variants in TM buffer containing
75 mM NaCl and 0.1% NP-40 (30 min, 4 C), and then
washed three times with the same buffer at 4 C. IT assembled
with wild-type UBF or mutated UBF derivatives was then
incubated with 7 mg HeLa nuclear extract in TM buffer
containing 75 mM NaCl and 0.03% NP-40 (30 min, 4 C), fol-
lowed by extensive washes with 75 mM NaCl and 90 mM
NaCl in TM buffer containing 0.03% NP-40 and 0.2 mg/ml
BSA at 4 C. In vitro transcription reactions were carried
out in a ﬁnal salt concentration of 90 mM NaCl.
In vitro protein–protein interaction assays
Flag-tagged or GST-fusion UBF deletion mutants were
expressed in insect (Sf9) cells and afﬁnity-puriﬁed on anti-
ﬂag M2 agarose (Sigma) or glutathione Sepharose beads by
nutating at 4 C for 1 h and then washing extensively. For
the analysis of the phosphorylation-dependent SL1 binding,
each immobilized UBF variant was then divided into two
aliquots. One aliquot was incubated in alkaline phosphatase
(AP) reaction buffer containing 1 U shrimp intestine AP
and the other in AP reaction buffer only, for 30 min at
30 C. Immobilized proteins were then washed three times
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EDTA, 10% glycerol) containing 0.4 M KCl and 1% NP-
40 and two times in TM buffer containing 0.1 M KCl and
0.1% NP-40. Ten micrograms of partially puriﬁed SL1
from HeLa cells was then added and nutated with the immo-
bilized proteins for 4 h at 4 C. The resulting complex was
washed four times in TM buffer containing 0.1 M KCl and
0.1% NP-40, eluted with 70 ml of BCO buffer (20 mM Tris
[pH 8.0], 0.5 mM EDTA, 20% glycerol, 1 M KCl, 1%
DOC) for 30 min at 4 C, and precipitated with a 1/4 volume
of 100% trichloroacetic acid (TCA) containing 4 mg/ml
sodium deoxycholate (DOC) at 4 C for 20 min. The pellet
was washed with 100% acetone, air dried, resuspended in
SDS sample buffer, and heated at 95 C for 3 min. Complexes
were separated by SDS-8% PAGE and transferred to nitrocel-
lulose membranes for western blot analysis. SL1 was detected
with anti-TAFI110 and anti-TBP polyclonal antibodies. All
washes and elution buffers contained a cocktail of protease
inhibitors and 1 mM DTT.
Transfection and co-immunoprecipitation assays
HEK293T cells were seeded 1 day before transfection. Cells
were transfected by calcium phosphate method with  12 mg
of DNA. At 19 h post-transfection, cells were lysed in TM
buffer containing 0.5 M NaCl and 0.1% NP-40. Cell lysate
was centrifuged at 44 K r.p.m. for 20 min and the supernatant
was then dialyzed in TM buffer containing 0.1 M NaCl and
0.1% NP-40 using a microdialyzer (Gibco). Flag-tagged pro-
teins were captured by incubation with anti-ﬂag M2 agarose
(Sigma). The resins were extensively washed with TM buffer
containing 0.1 M NaCl and 0.1% NP-40 and the bound
proteins were resolved by SDS–8% PAGE and transferred
to nitrocellulose membranes. Flag-tagged proteins were
visualized by Ponceau S staining and co-immunoprecipitated
proteins were detected by western blot analysis.
RESULTS
CK2 associates with the Pol I/Rrn3 complex and is
detected on the promoter but not on the coding and
termination regions of the rRNA genes
To determine whether CK2 is directly involved in Pol I tran-
scription, we examined if CK2 physically associates with any
of the essential components of the Pol I transcriptional
machinery. For this purpose, HeLa nuclear extracts were sub-
jected to several steps of column chromatography to separate
Pol I/Rrn3 and the two auxiliary factors, SL1 and UBF. The
resulting fractions were examined by western blot analysis
with antibodies speciﬁc for the b’subunit of Pol I, the
TAFI110 subunit of SL1, UBF, Rrn3, and the a subunit of
CK2. CK2 was detected in the fraction containing Pol I/
Rrn3 but not in the SL1 and UBF fractions (Figure 1A,
lanes 1–4). The ﬁnding that CK2 cofractionates with the
Pol I/Rrn3 complex but not with UBF and SL1 was conﬁrmed
in chromatographic fractionation of nucleolar extracts
(Figure 1B), which contain a population of proteins primarily
involved in the transcription and processing of rRNA. To
determine whether the subpopulation of CK2 that copuriﬁes
with the Pol I/Rrn3 complex is physically associated with
this complex, the fraction isolated from the nuclear extracts
that contains the Pol I/Rrn3 complex (Figure 1A, lane 4)
was then subjected to an immunoprecipitation reaction with
anti-CK2a antibody. The results of this experiment show
that Pol I and Rrn3 co-immunoprecipitate with CK2a
(Figure 1A, lane 5) but not with an unrelated nuclear protein
(TAFII32) (Figure 1A, lane 6), indicating that at least a
fraction of cellular CK2 is bound to the Pol I/Rrn3 complex.
To investigate the relevance of this interaction in Pol I
transcription, we then determined whether CK2 is recruited
to the rDNA sequences in vivo. The association of CK2
with the rDNA was examined in ChIP assays using sets of
primers speciﬁc for the promoter, the coding (18S RNA)
and the termination regions of the rRNA genes. We found
that Pol I (b0 subunit) and UBF are associated with all
three regions of the rRNA genes (Figure 1C). CK2a is also
present at the rRNA gene promoter but in contrast to Pol I
and UBF, it is not detected at the transcribed and the termina-
tion regions, suggesting that this kinase may play a speciﬁc
role in initiation of Pol I transcription. Moreover, if CK2 is
recruited to the promoter via interactions with the Pol I/
Rrn3 complex, the absence of detectable CK2 at the coding
and termination regions suggest that CK2, like Rrn3 (42), is
released from the polymerase upon transcription elongation.
CK2 kinase activity is required for Pol I transcription in
cultured cells and in vitro
To determine whether the kinase activity of CK2 plays a
role in the regulation of Pol I transcription, 293 cells were
incubated with 4,5,6,7-tetrabromobenzotriazole (TBB), a
speciﬁc inhibitor of CK2 kinase activity (43), or DMSO
(vehicle) for either 1, 2 or 4 h, and the endogenous level of
45S pre-rRNA was determined by nuclease S1 protection
assay or by reverse transcriptase RT–PCR. Since the probe
and primers used in these assays detect the extreme 50 end
of the external transcribed sequence of the rRNA precursor,
which is rapidly processed in the cell, these assays primarily
measure the rate of transcription initiation. As shown in
Figure 2A, both assays indicate that the addition of TBB
causes a sharp decrease in Pol I transcription (upper panel,
lanes 2, 3, 5 and 7; lower panel, lanes 2–4). The concentra-
tions of TBB used in this assay inhibit CK2 activity  80%
(43). In contrast, the level of a control mRNA (GAPDH) is
not affected by TBB (lower panel, lanes 2–4). A similar
level of inhibition of Pol I transcription by TBB was also
observed in studies carried out with human primary ﬁbro-
blasts (data not shown). In a complementary set of experi-
ments, we compared Pol I transcriptional activity in nuclear
extract prepared from TBB- and DMSO-treated 293 cells
using in vitro transcription assays with an rDNA reporter
construct. The results of these experiments indicate that
nuclear extracts prepared from TBB-treated cells have
 2-fold lower Pol I transcriptional activity than nuclear
extracts prepared from DMSO-treated cells (Figure 2B),
providing additional evidence that CK2 kinase activity is
required for optimal Pol I transcription. In addition, these
data suggest that inhibition of CK2 activity likely inﬂuences
the activity of one or more transcription factor. To investigate
further the direct requirement for CK2 activity in Pol I trans-
cription, we performed in vitro reconstituted transcription
assays with puriﬁed Pol I/Rrn3 fraction, which contains
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the puriﬁed proteins is shown in Figure 1A (lanes 2–4). The
partially puriﬁed components were mixed and preincubated
with TBB before nucleotides were added to start the tran-
scription reaction. As shown in Figure 2C, upper panel, pre-
incubation of puriﬁed factors with increasing amounts of
TBB resulted in a dose-dependant decrease of Pol I transcrip-
tional activity, indicating that inhibition of CK2-mediated
phosphorylation of one or more components of the Pol I
machinery drastically reduces transcription. This result is fur-
ther supported by studies showing that addition of a CK2
phosphoacceptor peptide but not an unrelated peptide (ﬂag
peptide) to an in vitro transcription reaction causes a decrease
in Pol I transcription (Figure 2C, lower panel). This CK2
phosphoacceptor peptide contains the consensus CK2 phos-
phorylatable sequence and has been shown to act as a compe-
titive substrate and inhibit CK2-dependent transcription by
Pol II and Pol III (37,40).
Figure 1. CK2 copurifies with the Pol I/Rrn3 complex and is present on the rRNA gene promoter region. (A) The protein kinase CK2 cofractionates and co-
immunoprecipitates with the RNA polymerase I/Rrn3 complex. Nuclear extracts prepared from HeLa S3 cells were fractionated by column chromatography and
the peak fractions containing UBF (lane 1), SL1 (lane 3), Pol I/Rrn3 (lane 4) were resolved by SDS–PAGE and analyzed for the presence of the indicated proteins
by western blot (lanes 1–4). Lane 2 contains recombinant UBF purified from baculovirus-infected Sf9 insect cells. The peak Pol I/Rrn3 fraction (lane 4) was
subjected to immunoprecipitation using goat polyclonal antibodies against CK2a (lane 5) or TAFII32 (lane 6), and the resulting products were analyzed by
western blot with antibody against the indicated factors. (B) Nucleolar extracts were prepared from four liters of HeLa S3 cells and loaded on a Poros HQ
column. The column was then subjected to a continuous salt gradient and aliquots of indicated fractions were tested for the presence of Pol I, SL1, CK2 and UBF
by western blot analysis as described in the Materials and Methods. (C) CK2 associates with the rRNA gene promoter but not with the coding and termination
regions. Cross-linked chromatin isolated from HeLa cells was immunnoprecipitated with rabbit non-immune serum (control), rabbit antisera against UBF and Pol
I b0 subunit (194 kDa), and goat polyclonal antibodies against TAFII32 and CK2. Immunoprecipitated chromatin was quantified by real-time PCR using primers
specific to the core promoter, 18S coding, and termination regions of the rRNA genes. The relative associations of indicated proteins with the three regions of the
rRNA genes are shown as the fold increases over non-immune serum (control). Graph shows means and standard deviations from triplicate real-time PCR
reactions and are representative of two independent ChIP assays.
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and UBF in cultured cells
To investigate the molecular mechanism by which CK2
regulates Pol I transcription, we determined whether CK2
activity affects the network of protein–protein interactions
involved in the assembly of the Pol I PIC. For this analysis,
we focused on the interactions between UBF and SL1 and
between Pol I and Rrn3, since these interactions are known
to be modulated by phosphorylation (14). Moreover, UBF
and Rrn3 appear to be cellular targets of CK2 since phospho-
peptide mapping of in vivo-labeled UBF and Rrn3 revealed
that peptides bearing CK2 phosphorylatable sites on both pro-
teins are indeed phosphorylated (44,45). 293T cells were trans-
fected with vectors expressing ﬂag-UBF (pCMV-ﬂag-UBF)
Figure 2. CK2 kinase activity is required for Pol I transcription in cultured cells and in vitro.( A) Inhibition of CK2 activity by treatment of 293 cells with TBB
down-regulates Pol I transcription. TBB was added to cells in culture at the final concentration of 80 mM. 45S pre-rRNA level was analyzed by nuclease S1
protection assay using 50 end-labeled DNA oligonucleotide complementary to the region from  20 to +40 of the rRNA gene (upper panel) or by RT–PCR (lower
panel). Either 5 mg (lanes 1–5) or 2.5 mg (lanes 6 and 7) of total RNA were used in the nuclease S1 protection assay. Products were resolved on an 8%
polyacrylamide gel and analyzed by autoradiography. Ribonuclease protection assays (RPA) to detect b-actin transcripts were used as an internal standard to
normalize the amounts of RNA used in the nuclease S1 protection assays. Intensities of bands were quantitated by phosphoimager analysis and are shown as
relative activities. (B) Nuclear extracts from TBB-treated cells have lower transcriptional activity than extracts from mock treated cells. In vitro transcription
reaction with a human rRNA template were carried out with nuclear extracts (3 mg, lanes 1 and 3; 5 mg, lanes 2 and 4) prepared from DMSO (mock)-treated
(lanes 1 and 2) and TBB-treated (lanes 3 and 4) HeLa cells and in vitro-synthesized RNA was analyzed by S1 nuclease protection assays. Relative activities were
determined by phosphoimager analysis. (C) Addition of TBB or a CK2 phosphoacceptor peptide to a reconstituted Pol I transcription system inhibits Pol I
transcriptional activity. Purified recombinant UBF was mixed with partially purified SL1 and Pol I/Rrn3 complex and incubated with TBB (upper panel) or CK2
phosphoacceptor peptide (lower panel) for 20 min at 30 C before in vitro transcription reaction were initiated by the addition of NTPs and a human rDNA
template. RNA products were analyzed by nuclease S1 protection assays as described in (A). Relative activities were determined by phosphoimager analysis. The
isoelectric point (pI) of the CK2 and flag peptides is 3.7 and 3.5, respectively. Data shown in this figure are representative of at least three independent
experiments.
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CK2 kinase inhibitor TBB or DMSO (vehicle). After 2 h of
continuous treatment, cells were lysed and subjected to
immunoprecipitation with anti-ﬂag agarose resin. Western
blot analysis of the immunoprecipitated products shows that
a smaller amount of SL1 is coimmunoprecipitated with
UBF in the extract from cell treated with TBB compared to
the extract from control cells (Figure 3A, lanes 3 and 4), sug-
gesting that the interaction between UBF and SL1 is reduced
in the cells treated with TBB. By contrast, the interaction of
Rrn3 with the polymerase is not affected by the treatment
with the CK2 kinase inhibitor, as similar amounts of Pol I b0
subunit were coimmunoprecipitated with Rrn3 from TBB-
and DMSO-treated cells (Figure 3B, lanes 3 and 4). SL1
and Pol I did not co-immunoprecipitate with an unrelated
ﬂag-tagged protein (ﬂag-lamin A, Figure 3C), conﬁrming
that the observed protein interactions were not due to non-
speciﬁc binding to the anti-ﬂag resin. Taken together, these
results provide evidence that the kinase activity of CK2 spe-
ciﬁcally inﬂuences the interaction between UBF and SL1.
SL1 makes direct contact with a 40 amino acid domain
in the C-terminus of UBF but the phosphorylation-
dependent regulation of the UBF–SL1 interaction
requires an extended region comprising HMG boxes 5
and 6 and the C-terminus
We have previously shown that the C-terminal region of UBF
is required for SL1 binding and further demonstrated that
phosphorylation of UBF is necessary for establishing a stable
UBF–SL1 complex at the rRNA gene promoter (14). How-
ever, the phosphoamino acid residues and the cellular kinase
involved in the phosphorylation-dependent binding of SL1
have not been identiﬁed. Notably, the C-terminal region of
UBF from amino acids 670 to 764 contains a series of serine
residues that are embedded within CK2 consensus sites (S/
TXXE/D). Moreover, this region is highly phosphorylated
in vivo and mutation of nine conserved serine sites within
this region of mouse UBF abolishes CK2 phosphorylation
within the acidic tail (44). To investigate the potential role
that phosphorylation within this region plays in the regulation
of SL1 binding, we ﬁrst mapped the minimal SL1 binding
region of UBF and then examined its dependence on phos-
phorylation. For this purpose, a series of UBF mutants con-
taining progressive truncations of the C-terminal region
were expressed and puriﬁed from baculovirus-infected insect
cells and incubated with partially puriﬁed SL1. After extens-
ive washes, the presence of bound SL1 was determined by
western blot analysis with TBP and TAFI110 antibodies. As
shown in Figure 4A, deletion of the last 18 amino acids of
UBF (UBF746C) does not affect the binding to SL1 (lane
4), while further deletion of an additional 18 amino acid resi-
dues (UBF728C) results in a signiﬁcant loss of binding (lane
3). Further deletions of the C-terminus (UBF706C and
UBF670C) completely eliminate SL1 binding (lanes 1 and
2), indicating that the region of UBF between amino acids
706 and 746 is required for this protein interaction. To deter-
mine whether this 40 amino acid region can bind to SL1 by
itself, we then carried out protein interaction assays using
GST-fusion UBF mutants spanning the C-terminal region of
UBF (Figure 4B). The results of this experiment show that
GST-UBF(706–746) (lane 2) binds to SL1 as well as
GST-UBF(670–746) (lane 3) and GST-UBF746C (lane 1),
conﬁrming that the region from amino acids 706 to 746
within the C-terminal domain of UBF makes direct contact
with SL1.
The treatment of recombinant full length UBF puriﬁed
from insect cells with AP causes a signiﬁcant reduction in
SL1 binding (14,27) (see also Figure 6C, lanes 1 and 2), sug-
gesting that phosphorylation of UBF regulates the interaction
between UBF and SL1. To determine whether the region of
UBF between amino acids 706 and 746 is also necessary
and sufﬁcient for the phosphorylation-dependent regulation
of this interaction, a series of UBF mutants were expressed
and puriﬁed from insect cells and treated with AP or buffer
before incubation with SL1. After extensive washes, the
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Figure 3. Inhibition of CK2 activity impairs the interaction between UBF and
SL1 in cultured cells. 293T cells were transfected with pCMV-flag-UBF,
pCMV-flag-Rrn3 and pCMV-flag-lamin A (negative control) using the
calcium phosphate method. At 19 h post-transfection, cells were treated with
TBB for 2 h and then lysed in TM buffer containing 0.5 M NaCl and 0.1%
NP-40. The lysates were dialyzed and incubated with anti-flag M2 agarose
resin. The products of the immunoprecipitation reactions from the cells
transfected with the constructs expressing flag-UBF (panel A, lanes 3 and 4),
flag-Rrn3 (panel B, lanes 3 and 4) or flag-lamin A (panel C, lane 2) were
separated by SDS–8% PAGE, transferred to nitrocellulose membranes and
analyzed by western blot with antibodies against two subunits of SL1 (panels
A and C; TAFI110 and TBP) and antibody against the largest subunit of RNA
polymerase I (panels B and C; polI b0). To assure that approximately equal
amounts of flag-tagged proteins were immunoprecipitated from the TBB- and
DMSO-treated cell extracts the membranes were stained by Ponceau S (lower
panels).
4758 Nucleic Acids Research, 2006, Vol. 34, No. 17bound proteins were resolved on an SDS–polyacrylamide gel
and the presence of SL1 was detected by western blot with
TBP antibody. The results of this experiment, shown in
Figure 5, indicate that the binding of SL1 to UBF
(706–746) was not signiﬁcantly affected by treatment with
AP (lanes 9 and 10), suggesting that this domain of UBF
binds to SL1 independently of its phosphorylation state.
This result was conﬁrmed in a protein interaction assay
with bacterially expressed UBF (706–746) (data not
shown). A similar result was also obtained with a slightly
longer UBF mutant [UBF (670–746), lanes 7 and 8]. In con-
trast, the phosphorylation-dependency of the interaction was
restored in the reaction containing UBF (491–746), a UBF
mutant that contains HMG boxes ﬁve and six in addition to
the C-terminal domain of UBF, since the AP-treated protein
shows a dramatic reduction in SL1 binding compared to the
mock-treated counterpart (lanes 5 and 6). These results sug-
gest that although SL1 binds to the region of UBF between
amino acids 706 and 746, the phosphorylation-dependent reg-
ulation of this molecular interaction requires the presence of
an additional region from amino acids 491 to 670 (HMG
boxes ﬁve and six). This interpretation is strongly supported
by the result showing that UBFdx, a UBF mutant missing
HMG boxes ﬁve and six, binds to SL1 equally well with
and without treatment with AP (lanes 3 and 4).
Phospho-ablation/mimicking mutants of UBF
indicate that phosphorylation of the C-terminus of
UBF by CK2 regulates SL1 binding
One possible interpretation of the results shown in Figure 5 is
that phosphorylation of serine residues within the region
between amino acids 491 and 670 regulates SL1 binding.
However, these results do not rule out that in the context of
the full length protein phosphorylation within the C-terminus
or in combination with the phosphorylation in HMG boxes
ﬁve and six are important for the regulation this interaction.
To address this question and to attempt to identify the phos-
phorylation sites critical for modulating this protein–protein
Figure 4. Mapping the SL1 binding domain of UBF. (A) Flag-tagged UBF (lane 5) and a set of UBF mutants containing progressive deletion of the C-terminal
region (UBF670C, lane 1; UBF706C, lane 2; UBF728C, lane 3; UBF746C, lane 4) were purified from insect cells infected with the respective recombinant
baculoviruses, immobilized on anti-flag resins, and incubated with partially purified SL1. After extensive washes, the bound proteins were eluted and analyzed
by western blotting with antibodies against two subunits of SL1 (TAFI110, upper panel; TBP, lower panel). Lane 6 contains 10% of the SL1 fraction used in the
interaction assays. Silver stained gel containing 20% of the beads-immobilized UBF mutants used in the protein interaction assays is shown in the bottom panel.
(B) GST-UBF746C (lane 1), GST-UBF(706–746) (lane 2), GST-UBF(670–746) (lane 3) and GST (lane 4) were purified from insect cells infected with the
respective recombinant baculoviruses, immobilized on glutathione resin and used in protein interaction assays with SL1 as described in (A). Lane 5 contains 10%
of the SL1 fraction used in the interaction assays. Silver stained gel containing 20% of the beads-immobilized UBF mutants used in the protein interaction assays
is shown in the lower panel. A schematic representation of UBF with its major functional domains [HMG boxes 1–6 and the C-terminal domain (CTD)] and the
mutants tested in the respective interaction assay is shown below each western blot. Each experiment was repeated three times with identical results.
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between amino acids 491 and 764 play any role in this regu-
latory process. This region of UBF contains 12 CK2 phos-
phorylatable serines and 9 of these sites are located within
the C-terminal domain, between amino acid 670 and 764
(Figure 6A). We therefore generated a series of phospho-
ablation and phospho-mimicking mutations by replacing
CK2 phosphorylatable serine residues with alanine/glycine
or glutamic/aspartic acid within the region from HMG box
ﬁve to the C-terminus of UBF (Figure 6B). Constructs encod-
ing ﬂag-tagged wild-type UBF, UBF670C and the set of
aforementioned mutants were transfected into 293T cells,
and the interaction of these proteins with endogenous SL1
was assessed by co-immunoprecipitation using anti-ﬂag
resin (Figure 6B). As expected, full length UBF binds well
to SL1 (lane 1) whereas UBF670C, which lacks the SL1 bind-
ing domain, fails to co-immunoprecipitate SL1 (lane 2). The
UBF mutant in which three serine residues on HMG box six
are mutated to alanines (UBF3A) binds to SL1 as well as the
wild-type protein (lane 3). On the other hand, the UBF mutant
with nine serines within the C-terminus substituted with
alanine/glycine residues (UBF9A/G) binds poorly to SL1
(lane 4). Mutations of these nine residues affect SL1 binding
independently of mutations at other CK2-acceptor sites, since
UBF with combined Ser to Ala/Gly substitutions in HMG box
six and the C-terminus (UBF3A + 9A/G) displays a SL1
binding capacity similar to UBF9A/G (lane 5). In contrast
to the alanine/glycine mutations, the substitution of CK2-
acceptor sites in HMG box six or in the C-terminus of UBF
with negatively charge residues, which mimic phosphorylated
amino acids, results in a similar or slightly better binding than
wild-type UBF (lanes 6 and 7, respectively). Analogous res-
ults were obtained in protein binding assays with truncated
UBF mutants [UBF (479–764) 9A/G and UBF (479–764)
9D/E; data not shown]. These results suggest that in the pres-
ence of HMG boxes 5 and 6, phosphorylation of CK2 phos-
phoacceptor serine residues located within the C-terminal
region between amino acids 670 and 764 regulates the inter-
action with SL1. In contrast, CK2 phosphoacceptor serines
outside this region do not seem to inﬂuence this interaction.
This interpretation is further supported by the observation
that in contrast to wild-type UBF, treatment of UBF9D/E
with AP does not inﬂuence SL1 binding (Figure 6C).
To examine the impact of UBF phosphorylation by CK2
on the recruitment of SL1 to the rRNA gene promoter, we
performed ChIP assays. Since endogenous UBF is potentially
a heterogeneous population with varying degrees of
phosphorylation, we speciﬁcally compared and contrasted
the recruitment of SL1 by the phospho-ablation and
phospho-mimicking UBF mutants UBF9A/G and UBF9D/E.
Figure 5. Mapping the region of UBF that is required for the phosphorylation-dependent regulation of this interaction. Flag-tagged or GST-fusion UBF deletion
mutants were expressed and purified from baculovirus-infected cells. Proteins were immobilized on the appropriate resins and equally divided into two aliquots.
One aliquot was subjected to alkaline phosphatase treatment while the other was incubated with buffer only. After the treatment, the immobilized proteins were
washed extensively, and tested in protein interaction assays with SL1 as described in Figure 4A. A schematic representation of UBF and UBF mutants used in this
analysis is shown below the western blot. Equal aliquots of flag-tagged and GST-fusion UBF mutants used in the protein interaction assays were resolved by
SDS–PAGE and silver stained (lower panel). Asterisk denotes antibody heavy chain band in lanes 1–4. The protein binding assays were repeated several times
with identical results.
4760 Nucleic Acids Research, 2006, Vol. 34, No. 17Figure 6. Protein interaction and ChIP assays with phospho-ablation and phospho-mimicking mutants of UBF. (A) Sequence of the region of UBF from amino
acids 491 to 764. This region includes HMG box 5 (from amino acids 490 to 546), HMG box six (from amino acids 568 to 634) and the C-terminal domain (CTD;
from amino acid 670 to 764). CK2 phosphoacceptor serine residues are shown in bold. (B) 293T cells transfected with constructs expressing wild-type and
mutant forms of UBF were lysed and incubated with anti-flag M2 agarose. After extensive washes, the bound proteins were separated by SDS–8% PAGE and
transferred to nitrocellulose membranes. The presence of SL1 in the immunoprecipitation products was determined by western blot analysis with antibody against
TBP (upper panel). The amounts of wild-type and mutant forms of UBF (middle panel) and TBP (lower panel) in the immunoprecipitation reactions was
determined by Ponceau S staining and western blot analysis, respectively. A schematic representation of the mutants generated in this study is shown. Phospho-
ablation and phospho-mimicking mutants of UBF were generated by replacing CK2 phosphorylatable serine residues with alanine/glycine or aspartate/glutamate by
site-directed mutagenesis. (C) Flag-tagged wild-type UBF and UBF 9D/E were expressed and purified from baculovirus-infected cells. Proteins were immobilized
on resins and equally divided into two aliquots. One aliquot was subjected to alkaline phosphatase treatment while the other was incubated with buffer only. After
the treatment, the immobilized proteins were washed extensively with dissociation buffer, and examined in protein interaction assays with SL1 as described in
Figure 4A. (D) 293 cells in 150 mm dishes were transfected with flag-UBF9A/G (20 mg) or flag-UBF9D/E (20 mg) using Lipofactamine 2000 (Invitrogen). After
30 h transfection, cross-linked chromatin was immunoprecipitated with rabbit non-immune serum (ctr), rabbit antisera against TAFI110 and TBP, and anti-FLAG
agarose beads. Immunoprecipitated chromatin was quantified by real-time PCR using primers specific to the core promoter of the rRNA genes. The relative
associations of indicated proteins are shown as the fold increases over non-immune serum (control). Graph shows means and standard deviations from triplicate
real-time PCR reactions and is representative of two independent ChIP assays. The differences in rRNA gene promoter recovered from chromatin
immunoprecipitations with TAFI110 and TBP antibodies between the two groups are statistically significant (p < 0.005). (E) Hypothetical model showing the
phosphorylation-induced conformational change in UBF that exposes the SL1 binding site within the C-terminal domain.
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or ﬂag-UBF9D/E and chromatin was immunoprecipitated
with antibodies against ﬂag, TAFI110 and TBP, and a
non-immune serum control. Immunoprecipitation with ﬂag
antibody show that UBF9A/G and UBF9D/E bind to the
rRNA gene promoter sequences with equal afﬁnities
(Figure 6D). No detectable amount of rRNA promoter
DNA immunoprecipitated with ﬂag antibody in cells trans-
fected with ﬂag-lamin A (data not shown). On the other
hand, the recovery of rRNA gene promoter sequences in
ChIP reactions with antibodies against TAFI110 and TBP in
cells expressing UBF9A/G was signiﬁcantly lower than in
cells expressing UBF9D/E. This result is likely an underesti-
mate of the difference in SL1 recruitment between the two
UBF variants since it assumes that the ﬂag protein occupies
all the rRNA promoter sites while is it likely that the trans-
fected proteins are associated with only a fraction of the
rRNA promoter sites.
Taken together, these results indicate that phosphorylation
of serines located within the carboxy terminal region of UBF
play an important role in SL1 binding. However, since the
C-terminal domain of UBF binds to SL1 regardless of its
phosphorylation status (Figure 5, lanes 7–10), our data sug-
gest that phosphorylation of this region of UBF is not directly
involved in SL1 binding but rather inﬂuences the accessibility
of this region to SL1, possibly through a phosphorylation-
induced conformational change (Figure 6E).
Phosphorylation of the C-terminus of UBF
promotes multiple rounds of transcription
To investigate the molecular mechanism by which phospho-
serine residues located within the C-terminal domain of UBF
affects transcription, we examined the effect of the nine
aforementioned phospho-ablation and phospho-mimicking
mutations on single and multiple rounds of transcription on
ITs (Figure 7A). In vitro transcription assays with ITs have
been useful to study the assembly of the PIC on the promoter
and their activities in single and multiple rounds of transcrip-
tion (46–48). Hence, a biotinylated human rRNA template
was immobilized on streptavidin-based magnetic bead and
incubated with puriﬁed wild-type UBF, UBF670C,
UBF9A/G or UBF9D/E. After the unbound proteins were
removed by extensive washes, the amounts of wild-type
UBF and mutated UBF variants bound to the ITs were
determined by western blot analysis. As shown in
Figure 7B, wild-type and mutant UBF proteins bind to the
ITs with equal afﬁnity. This result is in agreement with
previous studies showing that DNA binding of mammalian
UBF is mediated by the ﬁrst four HMG boxes (5,35). The
ITs bound to wild-type UBF and UBF mutants were then
incubated with nuclear extract prepared from HeLa cells to
allow the assembly of the PIC. The unbound proteins were
then removed by extensive washes and each PIC-assembled
template was split equally into eight aliquots and used in sin-
gle and multiple rounds of transcription assays. Calf thymus
DNA (ctDNA), which prevents RNA polymerase and other
factors from reassembling on the DNA template (48,49),
was added to the appropriate set of reactions to limit trans-
cription to a single round. Nucleotides were then added to
the PICs-assembled templates to start transcription and the
amount of transcripts generated in each reaction was determi-
ned at various time points by nuclease S1 protection assays.
In the single round of transcription assays the level of trans-
cripts generated by PICs with UBF9A/G or UBF9D/E is not
signiﬁcantly different from those generated by PIC with wild-
type UBF (Figure 7C, upper panel, lanes 1, 3–5, 7–9, 11–13,
15 and 16). By contrast, the PIC with UBF670C shows an
overall reduction in transcriptional activity at every time
point examined (Figure 7C, upper, lanes 2, 6, 10 and 14).
This result is in agreement with earlier data showing that
the C-terminal region of UBF plays an important role in
activation of Pol I transcription (5). Strikingly, while PICs
with wild-type UBF, UBF9A/G and UBF9D/E yield similar
levels of transcripts in single round reactions, the amount
of transcripts generated in the multiple rounds of transcription
by PIC with UBF9A/G (Figure 7C, lower panel, lanes 7, 11
and 15) are considerably lower than those generated by
PICs with wild-type UBF (lanes 1, 5, 9 and 13) or UBF9D/
E (lanes 4, 8, 12 and 16). The graph in Figure 7D shows
the proﬁle of multiple rounds of transcription reactions
from three independent experiments. These results indicate
that the amount of transcripts produced by the UBF9A/G-
assembled PIC does not increase signiﬁcantly after 5 min
of reaction, while the level of transcripts generated by PICs
with wild-type UBF and UBF9D/E show a steady increase
over time. Interestingly, PIC with UBF9D/E, which resem-
bles a constitutively phosphorylated UBF, is slightly more
efﬁcient than PIC with wild-type UBF in multiple rounds
of transcription. These ﬁndings suggest that the phosphoryla-
tion of nine CK2-acceptor serines on the C-terminus of UBF
is not essential for the initial assembly of a productive initia-
tion complex but is important for transcription re-initiation,
possibly through the stabilization of the interaction between
UBF and SL1 at the rRNA gene promoter.
DISCUSSION
Here we provide experimental evidence in support for a direct
role of CK2 in Pol I transcription. These results in combina-
tion with recently published data indicate that this protein
kinase regulates gene transcription by all three classes of
nuclear RNA polymerase (Pol I, II and III) in human cells.
While a relationship between Pol I transcription and CK2
has been implied by studies showing that mammalian UBF
is a substrate of CK2 (25,35,44) and CK2 cofractionates
with Pol I (50–52), the functional signiﬁcance of these ﬁnd-
ings was unknown. Our studies now show that Pol I transcrip-
tion activity in cultured cells is signiﬁcantly reduced upon
inhibition of endogenous CK2 with a speciﬁc chemical
inhibitor (TBB). This drug is highly speciﬁc for CK2 and
the concentrations used in our assays inhibit  80% of CK2
kinase activity (43,53). TBB-treated nuclear extracts also
display lower Pol I transcriptional activity than mock-treated
nuclear extracts and in vitro transcription assays with
partially puriﬁed proteins demonstrate that CK2 activity
directly regulates Pol I transcription. The fold effect on Pol
I transcription by CK2 observed in our transcription assays
is comparable to that of other regulatory factors that inﬂuence
the function of UBF, SL1 or Rrn3 (22,33,54–56) and that
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transcription (37,40).
Chromatographic fractionation and immunoprecipitation
experiments with extracts from human cells show that CK2
is associated with RNA polymerase I but not with UBF and
SL1, as observed in other organisms (50–52). Interestingly,
ChIP assays indicate that CK2 is found at the promoter of
the rRNA genes. However CK2, unlike Pol I, is not detected
at the 18S coding or termination regions of the rRNA genes,
suggesting that this protein kinase is recruited to the rRNA
gene promoter by Pol I but is then released from the poly-
merase upon the transition to transcription elongation. In
this scenario, CK2 would have access and phosphorylate tran-
scription factors that are only found at the promoter. This
would provide a ﬁne control mechanism that allows the
phosphorylation of the subpopulation of UBF found at the
promoter and involved in SL1 binding, but prevents that of
UBF molecules that are bound to other regions of the
rRNA gene. Since CK2 does not bind to UBF or SL1, it is
likely released from the rRNA gene promoter upon the
transition to transcription elongation. However, we cannot
rule out that CK2 remains at the promoter through inter-
actions with UBF or SL1 that may have been disrupted by
the experimental conditions used in the extract fractionation
studies.
Biochemical analyses have indicated that binding of UBF
to the rRNA gene promoter is critical for the recruitment of
SL1 and the assembly of a productive preintiation complex
Figure 7. Mutations of the CK2 phosphoacceptor sites in the C-terminus of UBF influence multiple rounds of transcription. (A) Scheme showing the
experimental approach used for the analysis of single and multiple rounds of transcription from PICs-assembled on immobilized templates. (B) Recombinant
wild type and UBF mutant proteins bind to immobilized rRNA template with similar efficiencies. Amounts of recombinant flag-tagged proteins bound to the
immobilized templates were determined by western blot analysis using antibodies against UBF. (C) The activities of wild-type UBF, UBF670C, UBF9A/G, and
UBF9D/E were examined in single (in the presence of calf thymus DNA) and multiple (in the absence of calf thymus DNA) rounds of transcription reactions as
described in the text. Single or multiple rounds of transcription reactions were initiated by the addition of nucleotides (NTPs) and stopped after either 2, 5, 10 or
20 min. The transcripts generated in each reaction were analyzed by nuclease S1 protection assays and autoradiography, and quantitated by phosphoimager
analysis. The results shown are representative of two single round and three multiple rounds of transcription, respectively. (D) Mean and standard deviations of
multiple rounds of transcription reactions from three independent experiments are represented graphically.
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are supported by cell-based studies, which showed that
association of UBF with the rRNA gene clusters is sufﬁcient
to recruit the Pol I transcriptional machinery to these loci
(19,20). A recent report has challenged this model and
suggested that SL1 stably binds to the rRNA gene promoter
in the absence of UBF (18). We have never observed a detect-
able binding of human SL1 to DNA by either DNA footprint-
ing or EMSA and our data support a key role for UBF in
nucleating the pre-initiation complex at the rRNA gene
promoter.
We have previously reported that phosphorylation of UBF
regulates the interaction between this factor and SL1 (14,27).
The C-terminal region of UBF is highly phosphorylated in
active growing cells (25,26,35), and its phosphorylation
state is modulated by signaling pathways activated by growth
factors (34,55). The C-terminal region of UBF is exception-
ally rich in serine, glutamic acid and aspartic acid residues
(4). This unusual amino acid composition has made the iden-
tiﬁcation of the phosphorylated amino acid residues by con-
ventional approaches particularly difﬁcult, and attempts to
map the phosphorylated sites within this region by mass
spectrometry have been unsuccessful. Yet, inspection of
UBF amino acid sequence indicates that the C-terminal
region contains several CK2 phosphoacceptor sites and
phosphorylation within this region by CK2 has been reported
by others (25,35,44). However, the function of UBF that is
regulated by CK2 phosphorylation was not determined.
Here we show that inhibition of CK2 activity in cultured
cells speciﬁcally affects the interaction between UBF and
SL1, suggesting a direct involvement of this protein kinase
in a regulatory process that inﬂuence transcription initiation.
In agreement with this ﬁnding, we demonstrated through
the analysis of a set of phospho-mimicking/ablation mutants
that nine CK2 phosphorylation sites on the carboxy-
terminus of UBF are important for binding to SL1. The
relevance of CK2-mediated phosphorylation within the C-
terminal domain of UBF in the transcription process is
underscored by the transcription assays with ITs, which
show that the phospho-ablation mutant UBF9A/G are
much less efﬁcient than wild-type UBF or phospho-
mimicking mutant UBF9D/E in promoting multiple rounds
of transcription.
We have previously reported that a kinase activity asso-
ciated with large T antigen phosphorylates UBF and regulate
the interaction of UBF with SL1 (27). Although we have
experimental evidence indicating that CK2 associates with
large T antigen, we have recently identiﬁed additional cellu-
lar kinases that bind to large T antigen (S. Navarro and
L. Comai, unpublished data) and studies are in progress to
determine the relative contribution of these kinases to UBF
phosphorylation and SL1 binding.
CK2 is a constitutively active protein kinase. This raises
the question of how it plays its regulatory role in Pol I tran-
scription. Since CK2 has been detected in the nucleolus of
active growing but not conﬂuent cells (59), it is likely that
the subcellular localization of CK2 is regulated by growth
signals. Consistent with this hypothesis, it has been shown
that CK2 can be transported from the cytoplasm to the
nucleus and nucleolus by direct interaction with ﬁbroblast
growth factor-2 (FGF-2) (60), suggesting that the recruitment
of CK2 to the rRNA gene promoter can be mediated by inter-
action with factors other than Pol I. Signiﬁcantly, a recent
study has indicated that FGF-2 can stimulate Pol I
transcription by binding to UBF (61).
UBF belongs to a subfamily of the HMG proteins (HMG1
proteins) that have one or more HMG1 box domains similar
to the High Mobility Group proteins 1 and 2. This family of
proteins is also characterized by the presence of an acidic
region at the C-terminus which commonly contains canonical
CK2 phosphorylation sites (62). Studies on HMG1 proteins
have revealed that CK2-mediated phosphorylation of the
acidic C-terminal domain induces a conformational change
in the HMG box domain, which affect its DNA binding
speciﬁcity (62,63). UBF contains six HMG1-like boxes and
the ﬁrst four (HMG boxes 1–4) are involved in DNA binding
(5,35). However HMG boxes 5 and 6 are not required for
DNA binding and their function was never well understood.
The data presented in this study suggest that the region
between HMG boxes 5 and 6 is required for conferring
the phosphorylation-dependency of the UBF–SL1 interaction
(Figure 5). Since this region does not bind directly to SL1, we
propose that phosphorylation of the C-terminal domain of
UBF induces a structural change in these HMG boxes
which makes the C-terminal region of UBF, from amino
acids 706 to 746, available for SL1 binding (Figure 6F). In
contrast, HMG boxes 1–4 do not appear to be structurally
affected by CK2 phosphorylation of the C-terminus
since the phospho-mimicking/ablation mutants of UBF bind
to the ITs equally well (Figure 7B). Clearly, the
phosphorylation-induced conformational change hypothesis
can only be rigorously tested through detailed structural
studies.
The critical role that CK2 plays in general transcription has
been recently emphasized by studies showing that this protein
kinase is present on the promoter of RNA Pol II- and III-
transcribed genes. Analyses carried out in the Hernandez
lab indicated that CK2 associates with the U6 promoter and
by phosphorylating components of the transcription complex,
it plays both positive and negative regulatory roles in
transcription by RNA polymerase III (38,39). Likewise,
experiments done in Reinberg lab have shown that CK2 is
associated with the downstream promoter element (DPE) of
a number of RNA polymerase II-transcribed genes and exerts
a positive effect on the transcription of these genes (40). Our
study, which provides evidence that CK2 also plays a critical
role in RNA polymerase I transcription, reinforces the
concept that this protein kinase is an important component
of all nuclear transcriptional machineries. In regard to Pol I
transcription, the experiments described in this study suggest
a model by which CK2 is recruited to the promoter via the
RNA polymerase I/Rrn3 complex and stimulates multiple
rounds of Pol I transcription by stabilizing the UBF–SL1
complex at the rRNA gene promoter through phosphorylation
of the C-terminal domain of UBF. In contrast, lack of phos-
phorylation at the reported sites would lead to the formation
of an unstable complex that rapidly disassembles from the
rRNA gene promoter. While this work underscores the func-
tional link between CK2 and UBF, we cannot rule out that
phosphorylation of other components of the PIC by CK2
may also inﬂuence Pol I transcription and future studies
will examine this possibility.
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